These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21667494)

  • 1. [Urinary liver type fatty acid binding protein (L-FABP)].
    Kamijo-Ikemori A; Sugaya T
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():406-9. PubMed ID: 21667494
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
    Sasaki H; Kamijo-Ikemori A; Sugaya T; Yamashita K; Yokoyama T; Koike J; Sato T; Yasuda T; Kimura K
    Nephron Clin Pract; 2009; 112(3):c148-56. PubMed ID: 19390215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary liver type fatty acid binding protein in diabetic nephropathy.
    Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
    Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary fatty acid binding protein in renal disease.
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Clin Chim Acta; 2006 Dec; 374(1-2):1-7. PubMed ID: 16860300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal L-type fatty acid--binding protein in acute ischemic injury.
    Yamamoto T; Noiri E; Ono Y; Doi K; Negishi K; Kamijo A; Kimura K; Fujita T; Kinukawa T; Taniguchi H; Nakamura K; Goto M; Shinozaki N; Ohshima S; Sugaya T
    J Am Soc Nephrol; 2007 Nov; 18(11):2894-902. PubMed ID: 17942962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does urinary L-type fatty acid-binding protein predict the severity of sepsis complicated by acute kidney injury?
    Oropello JM; Uppalapati A
    Crit Care Med; 2010 Oct; 38(10):2076-8. PubMed ID: 20856001
    [No Abstract]   [Full Text] [Related]  

  • 11. Cigarette smoking affects urinary liver-type fatty acid-binding protein concentration in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Koide H
    Diabetes Care; 2006 Jul; 29(7):1717. PubMed ID: 16801619
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis.
    Evennett NJ; Hall NJ; Pierro A; Eaton S
    J Pediatr Surg; 2010 Apr; 45(4):735-40. PubMed ID: 20385280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins.
    Thuijls G; van Wijck K; Grootjans J; Derikx JP; van Bijnen AA; Heineman E; Dejong CH; Buurman WA; Poeze M
    Ann Surg; 2011 Feb; 253(2):303-8. PubMed ID: 21245670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid-binding protein as marker for renal injury.
    Pelsers MM
    Scand J Clin Lab Invest Suppl; 2008; 241():73-7. PubMed ID: 18569970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary type IV collagen and urinary L-FABP].
    Araki S
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():186-90. PubMed ID: 27266085
    [No Abstract]   [Full Text] [Related]  

  • 17. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Sekizuka A; Hirata K; Kimura K
    Nephrol Dial Transplant; 2009 Mar; 24(3):788-800. PubMed ID: 18854419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction.
    Cronk DR; Houseworth TP; Cuadrado DG; Herbert GS; McNutt PM; Azarow KS
    Curr Surg; 2006; 63(5):322-5. PubMed ID: 16971202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Node K
    Am J Hypertens; 2007 Nov; 20(11):1195-201. PubMed ID: 17954367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid-binding proteins as plasma markers of tissue injury.
    Pelsers MM; Hermens WT; Glatz JF
    Clin Chim Acta; 2005 Feb; 352(1-2):15-35. PubMed ID: 15653098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.